CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-11 | Clapp Geoffrey Chief Product Officer | Sale 10b5-1 | −774 | $36.41 | $28K | 58,235 |
| 2026-11-10 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −120,213 | $35.61 | $4.3M | 827,389 |
| 2026-11-10 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −64,921 | $36.29 | $2.4M | 762,468 |
| 2026-11-10 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −33,437 | $35.61 | $1.2M | 729,031 |
| 2026-11-10 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −18,059 | $36.29 | $655K | 710,972 |
| 2026-11-10 | Schlanger David J Executive Chairman | Sale 10b5-1 | −35,392 | $35.36 | $1.3M | 238,462 |
| 2026-11-09 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −126,204 | $35.73 | $4.5M | 797,572 |
| 2026-11-09 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −35,104 | $35.73 | $1.3M | 762,468 |
| 2026-11-09 | Schlanger David J Executive Chairman | Sale 10b5-1 | −161,208 | $35.73 | $5.8M | 238,462 |
| 2026-11-05 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −3,400 | $35.23 | $120K | 806,111 |
| 2026-11-05 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −8,539 | $35.09 | $300K | 797,572 |
| 2026-11-05 | Schlanger David J Executive Chairman | Sale 10b5-1 | −3,400 | $35.22 | $120K | 238,462 |
| 2026-11-04 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −2,139 | $30.00 | $64K | 70,314 |
| 2026-10-14 | Cummings Melissa B Chief Operating Officer | Sale 10b5-1 | −1,879 | $28.00 | $53K | 66,496 |
| 2026-09-23 | Swartz Allison EVP, GC | Sale 10b5-1 | −3,903 | $26.10 | $102K | 75,816 |
| 2026-09-10 | GORDON KEVIN K Director | Sale | −11,500 | $27.12 | $312K | 6,792 |
| 2026-09-10 | GORDON KEVIN K Director | Sale | −11,500 | $27.94 | $321K | 6,792 |
| 2026-07-14 | Cummings Melissa B Chief Operating Officer | Sale 10b5-1 | −2,244 | $31.60 | $71K | 69,934 |
| 2026-06-04 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,918 | $25.50 | $49K | 75,287 |
| 2026-06-04 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −599 | $25.50 | $15K | 74,688 |
Page 1 of 40 · 786 trades